Melissa Hollo: Improving Pregnancy Outcomes in Pulmonary Arterial Hypertension
Melissa Hollo, Licensed Independent Clinical Social Worker, Director of Project Management at hc1, shared a post on LinkedIn about a recent article by Li Mu et al, published in European Journal of Obstetrics and Gynecology and Reproductive Biology, adding:
“Maternal health technology is making significant strides, benefiting both mothers and their babies.
A recent study published in the European Journal of Obstetrics and Gynecology and Reproductive Biology highlights that elevated SPP1 levels may help identify pregnant women with pulmonary arterial hypertension (PAH) who are at an increased risk for serious postpartum complications.
The research is compelling, and the next step is to integrate these advancements into routine clinical care.
Solutions like hc1 Clinical IQ HerCare assist health systems in operationalizing emerging evidence by:
- Identifying patients who may benefit from additional testing
- Supporting standardized care pathways
- Enabling earlier intervention
Earlier identification paves the way for better proactive care, steering maternal healthcare in a positive direction.
Learn how we’re supporting earlier maternal risk detection.”
Title: SPP1 improves early risk assessment of postpartum adverse events in pulmonary arterial hypertension complicated with pregnancy
Authors: Li Mu, Hui Yuan, Jun Zhang, Junyi Wu, Haofeng Zhang, Jiashu Yang
Stay updated on all scientific advances with Hemostasis Today.
-
Aug 4, 2026, 14:27What Detecting Atrial Fibrillation After Stroke Really Means for Patient Care – International Journal of Stroke
-
Aug 4, 2026, 14:19Caitlin Raymond: Unvaccinated Blood Requests and Their Impact on Patient Safety
-
Aug 4, 2026, 13:50Hamish Aitken-Buck: New Insights Challenge the Role of Histidine Rich Glycoprotein in Thrombosis
-
Aug 4, 2026, 13:38Michalis Gkionis: Dual-Domain Risk Assessment Simplifies Thrombosis Screening
-
Aug 4, 2026, 13:26Damien Luque Paz: Improving Myeloproliferative Neoplasm Diagnosis With Non Invasive Biomarkers
-
Aug 4, 2026, 13:16Anne Alnor: NLP Uncovers Hidden Cases of Pediatric Catheter-Associated Thrombosis
-
Aug 4, 2026, 13:04Danny Hsu: Improving TTP Diagnosis Through Expanded ADAMTS13 Access
-
Aug 4, 2026, 12:47Matthew Hotchko: The Evolving Landscape of the Fibrinogen Market
-
Aug 4, 2026, 12:03The Brain After iTTP Uncovering Hidden Cognitive Damage Through MRI